Tag #Apoe4

Showing 1 to 1 of 1 results

welt.de
🌐 75% Global Worthiness
News related image

Donanemab Approved for Early-Stage Alzheimer's with Stricter Guidelines

Donanemab, a new Alzheimer's drug, received conditional approval in Europe, slowing disease progression by up to six months in early stages for patients with mild cognitive impairment and only one copy of the ApoE4 gene, but with risks of brain swelling and bleeding.

Progress

48% Bias Score

Good Health and Well-being

Showing 1 to 1 of 1 results